Company Profiler: Revenue, Growth, Competition


505 Penobscot Dr
Redwood City, CA 94063

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Financial Information for Guardant Health

Guardant Health's revenue, profitability, growth rate by year. Trademarks and applications show Guardant Health's marketing strategy. Precise revenue figures by year, number of employees, and trademarks indicate Guardant Health's strengths. Guardant Health operates in the Medical Laboratories industry. A list of fastest growing competitors, and info on recession risks show Guardant Health's weaknesses relative to its competitors.

Access the complete profile.

Fast Facts

Revenue$10 - $100 million    Exact Revenue in Premium Report
Employees100 - 1,000Exact Employee Count Available in Premium Report
Primary Industry621511 Medical Laboratories
Additional NAICS Codes62151
Note: Revenues are statistical evaluations.

Guardant Health's Business Operations Profile shows critical firmographic facts:
  • What is the company's size? (Revenue and employees)
  • What industry is the company in?

Guardant Health Revenue and Growth Rate

Guardant Health Revenue Est.
($ Million)
Growth Rate (%)# Employees
2015Details in Premium Report

1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Guardant Health's revenues are gauged from an analysis of company filings.

Investor Activity

Guardant Health has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
August 9, 2017 17 100% $320 MM
Complete list of funding rounds and total amounts in the Company Report

Guardant Health's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Guardant Health Revenue (Sales) Guardant Health Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications, moreso than trademark registrations, show the products and services that are developing and being actively marketed. Companies that don't have any trademark applications are more likely to be stable, maintaining their existing business lines. Companies that are applying for new trademarks are likely to be investing in R&D and marketing, attempting to expand more rapidly or pivoting to reach strategic markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
Scientific research for medical purposes in the area of cancerous diseases; Structural and functional analysis of genomes; Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Diagnostic kits for cancer screening
Medical and scientific research in the field of cancer treatment and diagnosis; Structural and functional analysis of genomes; providing a database of patient medical diagnoses and reassessment information for use in medical and scientific research in the field of cancer; consulting services in the field of medical reassessment of treatment of cancer and assessing genomic predisposition of developing cancer for medical and scientific research purposes
Health care services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical testing for diagnostic or treatment purposes

See all trademarks in the Full Report.

Patent Applications

Patent applications show the company's intellectual property, as well as its current capabilities and future direction. Guardant Health has applied for 8 patents since 2009. Guardant Health's most recent patent was filed in May 2017 for Gene Mutations And Copy Number Alterations Of Egfr, Kras And Met. Sequence variants and copy number variations in the EGFR, KRAS and MET genes are biomarkers for resistance to anti-EGFR therapies for cancer. This disclosure provides methods of detecting these biomarkers and using them in the diagnosis and treatment of cancer.

Patent Application Date
Complete list of patent applications

Recession Risk

IncFact analyzed data from the last recession to determine whether Guardant Health grew or shrank over that period. We also looked at other companies in the industry to compare how recession-proof Guardant Health is relative to the industry. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Competition: Guardant Health vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Guardant Health, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)

Nearby Competition

Info on companies that are located in close proximity to Guardant Health, operating in similar markets. While some companies, particularly retail, compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Guardant Health's CompetitorsRevenue ($ MM)
Guardant Health Premium Report

Fastest Growing Competitors

These companies are in the same general field as Guardant Health and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Guardant Health Competitors